Evidence map›Paper›PMID 39684566›Full record

ReviewInternational journal of molecular sciences2024

Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging.

Vladimir S Sukhorukov, Tatiana I Baranich, Anna V Egorova, Anastasia V Akateva, Kseniia M Okulova, Maria S Ryabova, Krisitina A Skvortsova, Oscar V Dmitriev, Natalia M Mudzhiri, Dmitry N Voronkov and 1 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. A High-Fat Diet Induces Oxidative Stress in OPA1Antioxidants (Basel, Switzerland) · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Vladimir S SukhorukovLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.ORCID 0000-0002-0552-6939
Tatiana I BaranichLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Anna V EgorovaLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.ORCID 0000-0001-7112-2556
Anastasia V AkatevaLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Kseniia M OkulovaLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Maria S RyabovaLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Krisitina A SkvortsovaLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Oscar V DmitrievLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Natalia M MudzhiriLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Dmitry N VoronkovLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.
Sergey N IllarioshkinLaboratory of Neuromorphology, Brain Science Institute, Research Center of Neurology, Moscow 125367, Russia.ORCID 0000-0002-2704-6282

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2024-638
6 · The paper itself

Abstract

Mitochondrial dynamics significantly play a major role in the pathogenesis of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. The dysregulation of mitochondrial biogenesis and function, characterized by impaired fission and fusion processes mediated by a number of proteins, in particular, Drp1, Mfn1, Mfn2, Opa1, and PGC-1α, contributes to neuronal vulnerability and degeneration. Insufficient mitophagy and disrupted mitochondrial transport exacerbate oxidative stress and neurotoxicity. Emerging therapeutic strategies that target mitochondrial dynamics, including various pharmacological agents, demonstrate potential for restoring mitochondrial balance and enhancing neuroprotection. This growing body of research underscores the importance of mitochondrial health in developing effective interventions for neurodegenerative conditions. This review highlights well-established links between the disruption of mitochondrial dynamics and the development of neurodegenerative processes. We also discuss different therapeutic strategies that target mitochondrial function in neurons that have been proposed as perspective neuroprotective treatments.

Indexed as

AgingBrainMitochondriaMitochondrial DynamicsAnimalsHumansMitophagyNeurodegenerative DiseasesNeuronsOxidative Stressmitochondrial dynamicsmitophagyneurodegenerationneuroprotection

Identifiers

PMID39684566
PMCPMC11641149

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.